Johnson & Johnson reaches $5.5 billion settlement in talc-related cancer litigation

Johnson & Johnson has agreed to a $5.5 billion settlement to resolve thousands of lawsuits alleging its talc-based products are linked to ovarian cancer. This settlement represents a significant escalation in the company's efforts to resolve long-standing product liability litigation, though the final impact on the company's balance sheet remains subject to court approval and claimant participation.